Eden and Tirzepatide: The Compounded Dual-Agonist Program

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

From the PlexusDx Education Hub: how a telehealth program handles tirzepatide, the dual-agonist compound, and what to check before enrolling. Enter the Peptides & GLP-1 hub

Independent editorial review. PlexusDx has no affiliate relationship, sponsorship, or commercial tie to Eden or its parent company.

Full head-to-head: PlexusDx vs Eden →

Searches for "Eden tirzepatide" tend to come from people deciding between the branded drug and a compounded telehealth route. This review focuses on how Eden supplies tirzepatide and what the compounded pathway involves, in fair-balance terms rather than as a recommendation. Eden figures verified at checkout, July 2026.

Tirzepatide as a dual GIP/GLP-1 agonist

Tirzepatide differs from single-target GLP-1 drugs because it activates two incretin receptors at once — GIP and GLP-1. That dual action is the pharmacological reason it is studied as its own category rather than lumped with semaglutide. Like semaglutide, it works by influencing appetite signaling, gastric emptying, and glucose regulation, but through a broader receptor footprint.

How Eden dispenses compounded tirzepatide

Eden pairs telehealth with a 503A compounding pharmacy. After an online intake and clinician review, an approved prescription for compounded tirzepatide is fulfilled as an injection — Eden offers no oral tirzepatide. Follow-up visits handle titration and tolerability. Because pricing is set by compound rather than by dose, moving to a higher titration step does not, on its own, change what you are billed each month. Details and eligibility live on Eden's official website.

Branded tirzepatide vs the compounded route

Branded tirzepatide is an FDA-approved finished product; compounded tirzepatide is prepared by a licensed 503A pharmacy for an individual patient and is not an FDA-approved finished drug product. Telehealth programs use the compounded route largely to keep cash-pay pricing within reach. The molecule is the same dual agonist; the regulatory status and supply chain are what differ.

Eden's tirzepatide pricing at a glance

Eden advertises $199 per month for compounded tirzepatide (medication only), but the required Eden Membership adds $99 per month, bringing the true cost to $298 all-in per month. Billing is monthly, injection-only, priced by compound not dose, with nothing charged until approval and a 10%-in-six-months money-back warranty. PlexusDx Tirzepatide Injection runs $289 month to month, with Tirzepatide Oral at $349 — an option Eden lacks.

Trial evidence for tirzepatide

Tirzepatide's weight-management evidence comes chiefly from the SURMOUNT program, published in The New England Journal of Medicine in 2022, with SURMOUNT-OSA extending to obstructive sleep apnea in 2024. Semaglutide's STEP trials (2021) sit alongside as GLP-1 comparators. Trial doses, populations, and endpoints differ from compounded telehealth use, and results vary by person.

The metabolic baseline tirzepatide cannot read

Tirzepatide acts on receptors, but it cannot see the genetic terrain it lands in. TCF7L2 ties to glucose homeostasis and incretin signaling, GLP1R encodes one of tirzepatide's two receptor targets, and FTO and MC4R shape fat mass and satiety. These pathway-level variants do not predict response to tirzepatide, but they describe the biology a clinician prescribes into. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, and pairs with the PlexusDx Weight Management Protocols to add that upstream read.

No affiliation: PlexusDx is independent of Eden and holds no commercial relationship with any brand mentioned in this article.

More from PlexusDx: Zepbound Cost, Zepbound for Sleep Apnea, Zepbound Price, Cheap Zepbound.

Educational only. PlexusDx is not affiliated with Eden and compares tirzepatide approaches across GLP-1 telehealth, including its own Weight Management Protocols. The Precision Peptide Genetic Test reports how genes influence peptide-related pathways and does not predict response to tirzepatide or any medication. Consult a qualified healthcare provider before starting a protocol.

Look at the alternative: the PlexusDx Weight Management Protocols provide month-to-month tirzepatide in injection and oral formats, or take the Precision Peptide Genetic Test to read your metabolic pathway first.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education.

Frequently Asked Questions

Does Eden provide branded tirzepatide or a compounded version?

Eden dispenses compounded tirzepatide through a 503A pharmacy, prepared per prescription rather than sold as an FDA-approved finished product. It is supplied as an injection only, with no oral format. The active dual-agonist molecule matches the branded drug; the regulatory status differs. Verified July 2026.

What makes tirzepatide different from semaglutide?

Tirzepatide activates two incretin receptors — GIP and GLP-1 — while semaglutide targets GLP-1 alone. That dual mechanism is why tirzepatide is studied as its own category. Both influence appetite, gastric emptying, and glucose control, and both are available compounded through telehealth programs.

How much does Eden's tirzepatide program cost?

The advertised $199 monthly figure is medication only; a required $99 membership brings the true cost to $298 all-in per month. Billing is monthly, injection-only, and nothing is charged until a licensed provider approves the prescription.

Can a genetic test predict my tirzepatide response?

No. The Precision Peptide Genetic Test does not predict response to tirzepatide or any compound. It reports pathway-level variants such as TCF7L2 that describe baseline metabolic biology — context for a conversation with your provider, not a forecast of outcomes.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.